Trump Takes ‘Historic’ Action To Move Pharmaceutical Manufacturing Out Of China, Back To U.S.
By Ryan Saavedra In an “historic turning point,” the Trump administration has taken bold action to bring America’s pharmaceutical manufacturing back to the U.S. from China and India. “Seeking to secure the nation’s supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation’s first strategic stockpile of key ingredients needed to make medicines,” NBC News reported. “The agreement was signed Monday with Phlow Corp., a generic drug maker based in Virginia.” White House Trade Adviser Peter Navarro, a staunch China hawk who is the mastermind behind President Donald Trump’s trade war...
By Ryan Saavedra In an “historic turning point,” the Trump administration has taken bold action to bring America’s pharmaceutical manufacturing back to the U.S. from China and India. “Seeking to secure the nation’s supply of critical medications, the Trump...
click here for more